We are live on ! Find out more
AHL

Abel Hall LLC Portfolio holdings

AUM $579M
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
+54.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$428M
AUM Growth
+$181M
Cap. Flow
+$171M
Cap. Flow %
39.89%
Top 10 Hldgs %
29.78%
Holding
744
New
420
Increased
187
Reduced
56
Closed
30

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.65M
2
MSFT icon
Microsoft
MSFT
+$5.74M
3
AAPL icon
Apple
AAPL
+$4.37M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
AVGO icon
Broadcom
AVGO
+$2.31M

Top Sells

Rank Stock Value
1
WHR icon
Whirlpool
WHR
+$947K
2
OKE icon
Oneok
OKE
+$794K
3
NOG icon
Northern Oil and Gas
NOG
+$463K
4
RYN icon
Rayonier
RYN
+$434K
5
COOP
Mr. Cooper
COOP
+$387K

Sector Composition

Rank Sector Weight
1 Technology 17.12%
2 Financials 10.89%
3 Healthcare 8.13%
4 Industrials 6.66%
5 Consumer Discretionary 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TU icon
576
Telus
TU
$17.2B
$158K 0.04%
12,000
-129
-1% -$1.82K
DHC
577
Diversified Healthcare Trust
DHC
$2.19B
$155K 0.04%
+31,910
New +$145K
NMZ icon
578
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.21B
$153K 0.04%
+15,000
New +$158K
ACRE
579
Ares Commercial Real Estate
ACRE
$245M
$152K 0.04%
31,796
-138
-0.4% -$671
VTRS icon
580
Viatris
VTRS
$20.9B
$150K 0.04%
+12,054
New +$130K
ABUS icon
581
Arbutus Biopharma
ABUS
$857M
$148K 0.03%
+30,779
New +$138K
XRAY icon
582
Dentsply Sirona
XRAY
$2.87B
$148K 0.03%
+12,932
New +$152K
OXLC
583
Oxford Lane Capital
OXLC
$865M
$146K 0.03%
+10,000
New +$150K
EHAB
584
DELISTED
Enhabit
EHAB
$143K 0.03%
+15,524
New +$135K
GAIN icon
585
Gladstone Investment Corp
GAIN
$651M
$140K 0.03%
+10,000
New +$139K
MNKD icon
586
MannKind Corp
MNKD
$1.2B
$138K 0.03%
+24,269
New +$134K
AI icon
587
C3.ai
AI
$1.39B
$136K 0.03%
+10,061
New +$160K
COMP icon
588
Compass
COMP
$8.95B
$132K 0.03%
+12,475
New +$114K
EBS icon
589
Emergent Biosolutions
EBS
$382M
$129K 0.03%
+10,439
New +$112K
CC icon
590
Chemours
CC
$2.52B
$128K 0.03%
+10,898
New +$140K
ORC
591
Orchid Island Capital
ORC
$1.32B
$128K 0.03%
+17,776
New +$129K
LEG icon
592
Leggett & Platt
LEG
$1.41B
$128K 0.03%
+11,615
New +$114K
TRVI icon
593
Trevi Therapeutics
TRVI
$2.62B
$128K 0.03%
+10,191
New +$118K
ARVN icon
594
Arvinas
ARVN
$532M
$125K 0.03%
+10,534
New +$115K
OBDC icon
595
Blue Owl Capital
OBDC
$5.39B
$124K 0.03%
+10,000
New +$127K
CMPX icon
596
Compass Therapeutics
CMPX
$360M
$123K 0.03%
+22,882
New +$106K
WU icon
597
Western Union
WU
$2.53B
$120K 0.03%
12,884
-27,177
-68% -$240K
HFRO
598
Highland Opportunities and Income Fund
HFRO
$407M
$120K 0.03%
20,000
ERIC icon
599
Ericsson
ERIC
$32.4B
$117K 0.03%
+12,150
New +$115K
ARI
600
Apollo Commercial Real Estate
ARI
$866M
$116K 0.03%
11,995
-53
-0.4% -$530

Similar funds

Abel Hall LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Abel Hall LLC held 744 positions worth $428M, up 73% from $248M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Abel Hall LLC deployed $171M of net new capital in Q4 2025, opening 420 new positions and adding to 187 existing holdings. Its largest new stake was British American Tobacco: 18,744 shares worth $1.06M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Western Union, an estimated $240K trimmed.

  • Abel Hall LLC's largest Q4 2025 buy was British American Tobacco: 18,744 shares worth $1.06M.
  • Abel Hall LLC added most to NVIDIA in Q4 2025, an estimated $6.65M increase.
  • Abel Hall LLC's biggest Q4 2025 reduction was Western Union, cutting an estimated $240K.
  • Abel Hall LLC fully exited Whirlpool in Q4 2025, selling an estimated $947K.
  • Abel Hall LLC's ten largest holdings make up 30% of its $428M portfolio in Q4 2025.
  • Abel Hall LLC opened 420 new positions and closed 30 in Q4 2025.
  • Abel Hall LLC's portfolio value rose 73% quarter-over-quarter to $428M.

Based on Abel Hall LLC's 13F filing for Q4 2025, filed 17 Feb 2026.